Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

miR-132 suppresses transcription of ribosomal proteins to promote protective Th1 immunity.

Hewitson JP, Shah KM, Brown N, Grevitt P, Hain S, Newling K, Sharp TV, Kaye PM, Lagos D.

EMBO Rep. 2019 Apr;20(4). pii: e46620. doi: 10.15252/embr.201846620. Epub 2019 Mar 4.

PMID:
30833344
2.

[Working conditions among argentinean psychiatrists].

Cesoni M, Peskin VA, Berrío Cuartas DM, Tenconi JC, Furman M, Pereyra W, Furman M, Ibañez B, Baratti M, Lagos D, García N, Mendieta M, Sínchez F.

Vertex. 2018 Jul;XXIX(140):299-306. Spanish. No abstract available.

PMID:
30778424
3.

Tissue and host species-specific transcriptional changes in models of experimental visceral leishmaniasis.

Ashwin H, Seifert K, Forrester S, Brown N, MacDonald S, James S, Lagos D, Timmis J, Mottram JC, Croft SL, Kaye PM.

Version 2. Wellcome Open Res. 2019 Jan 2 [revised 2019 Jan 1];3:135. doi: 10.12688/wellcomeopenres.14867.2. eCollection 2018.

4.

Activation of mitochondrial aldehyde dehydrogenase (ALDH2) by ALDA-1 reduces both the acquisition and maintenance of ethanol intake in rats: A dual mechanism?

Rivera-Meza M, Vásquez D, Quintanilla ME, Lagos D, Rojas B, Herrera-Marschitz M, Israel Y.

Neuropharmacology. 2019 Mar 1;146:175-183. doi: 10.1016/j.neuropharm.2018.12.001. Epub 2018 Dec 4.

PMID:
30521820
5.
6.

A HIF-LIMD1 negative feedback mechanism mitigates the pro-tumorigenic effects of hypoxia.

Foxler DE, Bridge KS, Foster JG, Grevitt P, Curry S, Shah KM, Davidson KM, Nagano A, Gadaleta E, Rhys HI, Kennedy PT, Hermida MA, Chang TY, Shaw PE, Reynolds LE, McKay TR, Wang HW, Ribeiro PS, Plevin MJ, Lagos D, Lemoine NR, Rajan P, Graham TA, Chelala C, Hodivala-Dilke KM, Spendlove I, Sharp TV.

EMBO Mol Med. 2018 Aug;10(8). pii: e8304. doi: 10.15252/emmm.201708304.

7.

GDF11 Modulates Ca2+-Dependent Smad2/3 Signaling to Prevent Cardiomyocyte Hypertrophy.

Duran J, Troncoso MF, Lagos D, Ramos S, Marin G, Estrada M.

Int J Mol Sci. 2018 May 18;19(5). pii: E1508. doi: 10.3390/ijms19051508.

8.

Effect of formulation and baking conditions on the structure and development of non-enzymatic browning in biscuit models using images.

Leiva-Valenzuela GA, Quilaqueo M, Lagos D, Estay D, Pedreschi F.

J Food Sci Technol. 2018 Apr;55(4):1234-1243. doi: 10.1007/s13197-017-3008-7. Epub 2018 Feb 20.

9.

Occurrence of Methylmercury in Rice-Based Infant Cereals and Estimation of Daily Dietary Intake of Methylmercury for Infants.

Cui W, Liu G, Bezerra M, Lagos DA, Li Y, Cai Y.

J Agric Food Chem. 2017 Nov 8;65(44):9569-9578. doi: 10.1021/acs.jafc.7b03236. Epub 2017 Oct 25.

PMID:
29067797
10.

MicroRNA-155 induction via TNF-α and IFN-γ suppresses expression of programmed death ligand-1 (PD-L1) in human primary cells.

Yee D, Shah KM, Coles MC, Sharp TV, Lagos D.

J Biol Chem. 2017 Dec 15;292(50):20683-20693. doi: 10.1074/jbc.M117.809053. Epub 2017 Oct 24.

11.

Conserved asymmetry underpins homodimerization of Dicer-associated double-stranded RNA-binding proteins.

Heyam A, Coupland CE, Dégut C, Haley RA, Baxter NJ, Jakob L, Aguiar PM, Meister G, Williamson MP, Lagos D, Plevin MJ.

Nucleic Acids Res. 2017 Dec 1;45(21):12577-12584. doi: 10.1093/nar/gkx928.

12.

Ca2+/Calmodulin-Dependent Protein Kinase II and Androgen Signaling Pathways Modulate MEF2 Activity in Testosterone-Induced Cardiac Myocyte Hypertrophy.

Duran J, Lagos D, Pavez M, Troncoso MF, Ramos S, Barrientos G, Ibarra C, Lavandero S, Estrada M.

Front Pharmacol. 2017 Sep 11;8:604. doi: 10.3389/fphar.2017.00604. eCollection 2017.

13.

Argonaute Utilization for miRNA Silencing Is Determined by Phosphorylation-Dependent Recruitment of LIM-Domain-Containing Proteins.

Bridge KS, Shah KM, Li Y, Foxler DE, Wong SCK, Miller DC, Davidson KM, Foster JG, Rose R, Hodgkinson MR, Ribeiro PS, Aboobaker AA, Yashiro K, Wang X, Graves PR, Plevin MJ, Lagos D, Sharp TV.

Cell Rep. 2017 Jul 5;20(1):173-187. doi: 10.1016/j.celrep.2017.06.027.

14.

microRNAs in the Lymphatic Endothelium: Master Regulators of Lineage Plasticity and Inflammation.

Yee D, Coles MC, Lagos D.

Front Immunol. 2017 Feb 9;8:104. doi: 10.3389/fimmu.2017.00104. eCollection 2017. Review.

15.

GSK-3β/NFAT Signaling Is Involved in Testosterone-Induced Cardiac Myocyte Hypertrophy.

Duran J, Oyarce C, Pavez M, Valladares D, Basualto-Alarcon C, Lagos D, Barrientos G, Troncoso MF, Ibarra C, Estrada M.

PLoS One. 2016 Dec 15;11(12):e0168255. doi: 10.1371/journal.pone.0168255. eCollection 2016.

16.

IL-36γ has proinflammatory effects on human endothelial cells.

Bridgewood C, Stacey M, Alase A, Lagos D, Graham A, Wittmann M.

Exp Dermatol. 2017 May;26(5):402-408. doi: 10.1111/exd.13228. Epub 2017 Mar 2.

17.

Optimization of a landfill gas collection shutdown based on an adapted first-order decay model.

Lagos DA, Héroux M, Gosselin R, Cabral AR.

Waste Manag. 2017 May;63:238-245. doi: 10.1016/j.wasman.2016.08.012. Epub 2016 Aug 17.

PMID:
27544724
18.

S6K2-mediated regulation of TRBP as a determinant of miRNA expression in human primary lymphatic endothelial cells.

Warner MJ, Bridge KS, Hewitson JP, Hodgkinson MR, Heyam A, Massa BC, Haslam JC, Chatzifrangkeskou M, Evans GJ, Plevin MJ, Sharp TV, Lagos D.

Nucleic Acids Res. 2016 Nov 16;44(20):9942-9955. Epub 2016 Jul 12.

19.

Suppression of AGO2 by miR-132 as a determinant of miRNA-mediated silencing in human primary endothelial cells.

Leonov G, Shah K, Yee D, Timmis J, Sharp TV, Lagos D.

Int J Biochem Cell Biol. 2015 Dec;69:75-84. doi: 10.1016/j.biocel.2015.10.006. Epub 2015 Oct 19.

20.

Dissecting the roles of TRBP and PACT in double-stranded RNA recognition and processing of noncoding RNAs.

Heyam A, Lagos D, Plevin M.

Wiley Interdiscip Rev RNA. 2015 May-Jun;6(3):271-89. doi: 10.1002/wrna.1272. Epub 2015 Jan 28. Review.

PMID:
25630541
21.

Kaposi's sarcoma herpesvirus microRNAs induce metabolic transformation of infected cells.

Yogev O, Lagos D, Enver T, Boshoff C.

PLoS Pathog. 2014 Sep 25;10(9):e1004400. doi: 10.1371/journal.ppat.1004400. eCollection 2014 Sep.

22.

Aphis (Hemiptera: Aphididae) species groups found in the Midwestern United States and their contribution to the phylogenetic knowledge of the genus.

Lagos DM, Voegtlin DJ, Coeur d'acier A, Giordano R.

Insect Sci. 2014 Jun;21(3):374-91. doi: 10.1111/1744-7917.12089. Epub 2014 Jan 15.

PMID:
24302699
23.

A transcriptomic network identified in uninfected macrophages responding to inflammation controls intracellular pathogen survival.

Beattie L, d'El-Rei Hermida M, Moore JW, Maroof A, Brown N, Lagos D, Kaye PM.

Cell Host Microbe. 2013 Sep 11;14(3):357-68. doi: 10.1016/j.chom.2013.08.004.

24.

The microRNA-30 family targets DLL4 to modulate endothelial cell behavior during angiogenesis.

Bridge G, Monteiro R, Henderson S, Emuss V, Lagos D, Georgopoulou D, Patient R, Boshoff C.

Blood. 2012 Dec 13;120(25):5063-72. doi: 10.1182/blood-2012-04-423004. Epub 2012 Oct 18.

25.

Spatial distribution of Aphis glycines (Hemiptera: Aphididae): a summary of the suction trap network.

Schmidt NP, O'Neal ME, Anderson PF, Lagos D, Voegtlin D, Bailey W, Caragea P, Cullen E, DiFonzo C, Elliott K, Gratton C, Johnson D, Krupke CH, McCornack B, O'Neil R, Ragsdale DW, Tilmon KJ, Whitworth J.

J Econ Entomol. 2012 Feb;105(1):259-71.

PMID:
22420279
26.

Exploring the interaction between siRNA and the SMoC biomolecule transporters: implications for small molecule-mediated delivery of siRNA.

Gooding M, Tudzarova S, Worthington RJ, Kingsbury SR, Rebstock AS, Dube H, Simone MI, Visintin C, Lagos D, Quesada JM, Laman H, Boshoff C, Williams GH, Stoeber K, Selwood DL.

Chem Biol Drug Des. 2012 Jan;79(1):9-21. doi: 10.1111/j.1747-0285.2011.01249.x. Epub 2011 Nov 4.

PMID:
21981778
27.

Noncoding RNAs and cancer.

Yogev O, Lagos D.

Silence. 2011 Sep 29;2(1):6. doi: 10.1186/1758-907X-2-6.

28.

Immunobiology and host response to KSHV infection.

Lagos D, Boshoff C.

In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 52.

29.

LIM-domain proteins, LIMD1, Ajuba, and WTIP are required for microRNA-mediated gene silencing.

James V, Zhang Y, Foxler DE, de Moor CH, Kong YW, Webb TM, Self TJ, Feng Y, Lagos D, Chu CY, Rana TM, Morley SJ, Longmore GD, Bushell M, Sharp TV.

Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12499-504. doi: 10.1073/pnas.0914987107. Epub 2010 Jun 28.

30.

miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator.

Lagos D, Pollara G, Henderson S, Gratrix F, Fabani M, Milne RS, Gotch F, Boshoff C.

Nat Cell Biol. 2010 May;12(5):513-9. doi: 10.1038/ncb2054. Epub 2010 Apr 25.

PMID:
20418869
31.

KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming.

Hansen A, Henderson S, Lagos D, Nikitenko L, Coulter E, Roberts S, Gratrix F, Plaisance K, Renne R, Bower M, Kellam P, Boshoff C.

Genes Dev. 2010 Jan 15;24(2):195-205. doi: 10.1101/gad.553410.

32.

KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia.

Emuss V, Lagos D, Pizzey A, Gratrix F, Henderson SR, Boshoff C.

PLoS Pathog. 2009 Oct;5(10):e1000616. doi: 10.1371/journal.ppat.1000616. Epub 2009 Oct 9.

33.

The CD8 and CD4 T-cell response against Kaposi's sarcoma-associated herpesvirus is skewed towards early and late lytic antigens.

Robey RC, Lagos D, Gratrix F, Henderson S, Matthews NC, Vart RJ, Bower M, Boshoff C, Gotch FM.

PLoS One. 2009 Jun 17;4(6):e5890. doi: 10.1371/journal.pone.0005890.

34.

Toll-like receptor 4 mediates innate immunity to Kaposi sarcoma herpesvirus.

Lagos D, Vart RJ, Gratrix F, Westrop SJ, Emuss V, Wong PP, Robey R, Imami N, Bower M, Gotch F, Boshoff C.

Cell Host Microbe. 2008 Nov 13;4(5):470-83. doi: 10.1016/j.chom.2008.09.012.

35.

Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a case-control study.

Mutalima N, Molyneux E, Jaffe H, Kamiza S, Borgstein E, Mkandawire N, Liomba G, Batumba M, Lagos D, Gratrix F, Boshoff C, Casabonne D, Carpenter LM, Newton R.

PLoS One. 2008 Jun 18;3(6):e2505. doi: 10.1371/journal.pone.0002505.

36.

Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells.

Vart RJ, Nikitenko LL, Lagos D, Trotter MW, Cannon M, Bourboulia D, Gratrix F, Takeuchi Y, Boshoff C.

Cancer Res. 2007 May 1;67(9):4042-51.

37.

The transformer gene in Bactrocera oleae: the genetic switch that determines its sex fate.

Lagos D, Koukidou M, Savakis C, Komitopoulou K.

Insect Mol Biol. 2007 Apr;16(2):221-30. Epub 2007 Feb 6.

PMID:
17298554
38.

Kaposi sarcoma as a model of oncogenesis and cancer treatment.

Hansen A, Boshoff C, Lagos D.

Expert Rev Anticancer Ther. 2007 Feb;7(2):211-20. Review.

PMID:
17288530
39.

Kaposi sarcoma herpesvirus-encoded vFLIP and vIRF1 regulate antigen presentation in lymphatic endothelial cells.

Lagos D, Trotter MW, Vart RJ, Wang HW, Matthews NC, Hansen A, Flore O, Gotch F, Boshoff C.

Blood. 2007 Feb 15;109(4):1550-8. Epub 2006 Oct 17.

40.

A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1.

Newton R, Carpenter L, Casabonne D, Beral V, Babiker A, Darbyshire J, Weller I, Weiss R, Kwan A, Bourboulia D, Munoz F, Lagos D, Boshoff C.

Br J Cancer. 2006 May 22;94(10):1504-9.

42.

Development of the choices and acquisition of antibiotics model from a descriptive study of a lay Honduran population.

Crigger NJ, Holcomb L, Grogan RL, Vasquez M, Parchment C, Almendares J, Lagos D.

Int J Nurs Stud. 2004 Sep;41(7):745-53.

PMID:
15288797
43.

Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma.

Wang HW, Trotter MW, Lagos D, Bourboulia D, Henderson S, Mäkinen T, Elliman S, Flanagan AM, Alitalo K, Boshoff C.

Nat Genet. 2004 Jul;36(7):687-93. Epub 2004 Jun 27.

PMID:
15220918
44.

Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia.

Bourboulia D, Aldam D, Lagos D, Allen E, Williams I, Cornforth D, Copas A, Boshoff C.

AIDS. 2004 Feb 20;18(3):485-93.

PMID:
15090801
45.

Turnover-based in vitro selection and evolution of biocatalysts from a fully synthetic antibody library.

Cesaro-Tadic S, Lagos D, Honegger A, Rickard JH, Partridge LJ, Blackburn GM, Plückthun A.

Nat Biotechnol. 2003 Jun;21(6):679-85. Epub 2003 May 18.

PMID:
12754520
46.

Treatment of herpes zoster with interferon alpha-2A.

Naoum C, Perissios A, Varnavas V, Lagos D.

Int J Dermatol. 1996 Oct;35(10):749-50. No abstract available.

PMID:
8891834
47.

Unusual gunshot wound of abdomen.

Lagos DO, Aguam AS, Wilder JR.

N Y State J Med. 1978 Jan;78(1):78-9. No abstract available.

PMID:
272502

Supplemental Content

Support Center